Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis. (Q50981184)
Jump to navigation
Jump to search
scientific article published on 6 August 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis. |
scientific article published on 6 August 2013 |
Statements
Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis. (English)
1 reference
Sirpa Jalkanen
1 reference
Woo-Yong Lee
1 reference
Marko Salmi
1 reference
Margaret M Kelly
1 reference
Paul Kubes
1 reference
6 August 2013
1 reference
58
1 reference
4
1 reference
1413-1423
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference